SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare soars on receiving contract from pharmaceutical distribution company in UK

17 Feb 2025 Evaluate

Remedium Lifecare is currently trading at Rs. 3.97, up by 0.18 points or 4.75% from its previous closing of Rs. 3.79 on the BSE.

The scrip opened at Rs. 3.97 and has touched a high and low of Rs. 3.97 and Rs. 3.87 respectively. So far 5000720 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 1 has touched a 52 week high of Rs. 38.25 on 26-Feb-2024 and a 52 week low of Rs. 3.65 on 14-Feb-2025.

Last one week high and low of the scrip stood at Rs. 3.97 and Rs. 3.65 respectively. The current market cap of the company is Rs. 160.07 crore.

The promoters holding in the company stood at 1.11%, while Non-Institutions held 98.89% stake in the company.

Remedium Lifecare has received a multi-year supply contract from a pharmaceutical distribution company based in the United Kingdom. This contract includes the supply of a range of Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The estimated value of the supplies scheduled from February 2025 to January 2026 alone is valued around Rs 182.70 crore. 

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.

Supha Pharmachem Share Price

0.48 0.02 (4.35%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 227.35
Adani Enterprises 2225.25
Amrapali Industries 17.27
Rashi Peripheral 474.40
PDS 291.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×